Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Report Description
Hemostasis is a natural process that stops blood loss in case of an injury or incision on the body. The process of hemostasis involves three major steps that includes vascular spasm, platelet plug formation, and coagulation. Maintaining hemostasis is one of the crucial step for clinicians working on surgical procedures and trauma management. Thus, commercially available hemostats and tissue sealing agents play an important role in preventing blood loss in cases of uncontrolled bleeding. These hemostats and tissue sealants are available in the market in the form of patches, powders, gels, sponges, and other formulations that are intended to perform the same function of controlling excessive blood flow.
Market Dynamics
Hemostats and tissue sealants are used in a wide range of medical applications that include hernia fixation surgery, orthopedic surgery, spinal injury, trauma or accident wound closure, ophthalmic injuries or replacements, burns, neurosurgeries, urological disorders, and other chronic conditions to control excessive bleeding. Thus, increasing number of surgical procedures is expected to be a major factor augmenting growth of the global hemostasis and tissue sealing agents market. For instance, according to the Wound Management Innovation Center, 2015, wounds are estimated to affect over 433,000 people in Australia and the economic burden is estimated to be around US$ 2.85 billion per year. Moreover, according to The World Bank in 2012, the number of surgical procedures performed per 100,000 population were accounted to be 4,511 globally. However, lack of reimbursement for these agents and products could hinder the market growth.
Key features of the study:
• This report provides in-depth analysis of hemostasis & tissue sealing agents market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 - 2025), considering 2016 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global hemostasis & tissue sealing agents market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study includes Cryolife, Inc. Baxter International, Inc., Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc., Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global hemostasis & tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the hemostasis & tissue sealing agents market
Detailed Segmentation:
• Global Hemostasis & Tissue Sealing Agents Market, By Product Type:
o Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
o Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
• Global Hemostasis & Tissue Sealing Agents Market, By End User:
o Hospitals
o Ambulatory Surgical Centers
o Home Care Settings
• Global Hemostasis & Tissue Sealing Agents Market, By Geography:
o North America
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
U.S.
Canada
o Latin America
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
Brazil
Mexico
Rest of Latin America
o Europe
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
GCC
Israel
Rest of Middle East
o Africa
By Product Type:
Topical Hemostats
Mechanical Hemostats
Collagen Based Hemostats
Cellulose Based Hemostats
Gelatin Based Hemostats
Polysaccharide Based Hemostats
Active Hemostats
Flowable Hemostats
Adhesives & Tissue Sealing Agents
Natural Tissue Sealants
Synthetic Tissue Sealants
Adhesion Barrier Products
By End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
By Country:
South Africa
Central Africa
North Africa
• Company Profiles
o Cryolife, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
o Baxter International, Inc.
o Ethicon LLC
o Integra Lifesciences Corporation
o Becton, Dickinson & Company
o Cohera Medical, Inc.
o Pfizer, Inc.
o Medtronic
o B. Braun Melsungen AG
o MIL Laboratories Pvt. Ltd
o Advanced Medical Solutions Group Plc
"*" marked represents similar segmentation in other categories in the respective section.